Morgan Stanley gives an Overweight recommendation for Cidara Therapeutics Inc (CDTX)

Samantha Gray

Cidara Therapeutics Inc’s recently made public that its Chief Medical Officer Davarpanah Nicole Negar unloaded Company’s shares for reported $29797.0 on Sep 11 ’25. In the deal valued at $62.86 per share,474 shares were sold. As a result of this transaction, Davarpanah Nicole Negar now holds 31,418 shares worth roughly $3.14 million.

Then, RA CAPITAL MANAGEMENT, L.P. bought 2,272,727 shares, generating $99,999,988 in total proceeds. Upon buying the shares at $44.00, the Director now owns 3,365,523 shares.

Before that, Mineo Chrysa bought 2,270 shares. Cidara Therapeutics Inc shares valued at $49,281 were divested by the Director at a price of $21.71 per share. As a result of the transaction, Mineo Chrysa now holds 2,270 shares, worth roughly $0.23 million.

Morgan Stanley initiated its Cidara Therapeutics Inc [CDTX] rating to an Overweight in a research note published on October 16, 2025; the price target was $190. A number of analysts have revised their coverage, including JP Morgan’s analysts, who began to cover the stock in early October with a ‘”an Overweight”‘ rating. Citizens JMP started covering the stock on March 12, 2025. It rated CDTX as “a Mkt outperform”.

Price Performance Review of CDTX

On Monday, Cidara Therapeutics Inc [NASDAQ:CDTX] saw its stock jump 7.37% to $99.98. Over the last five days, the stock has lost -0.58%. Cidara Therapeutics Inc shares have risen nearly 784.78% since the year began. Nevertheless, the stocks have risen 271.95% over the past one year. While a 52-week high of $121.21 was reached on 10/10/25, a 52-week low of $11.28 was recorded on 04/07/25.

Levels Of Support And Resistance For CDTX Stock

The 24-hour chart illustrates a support level at 94.64, which if violated will result in even more drops to 89.30. On the upside, there is a resistance level at 105.18. A further resistance level may holdings at 110.37.

How much short interest is there in Cidara Therapeutics Inc?

A steep rise in short interest was recorded in Cidara Therapeutics Inc stocks on 2025-10-15, growing by 0.79 million shares to a total of 2.98 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 2.19 million shares. There was a rise of 26.45%, which implies that there is a positive sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.